Publication & Citation Trends
Most Cited Works
Publications
84 total
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials PDF
Cited by 26
OpenAlex
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
Cited by 131
OpenAlex
Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study PDF
Cited by 59
OpenAlex
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
Cited by 346
OpenAlex
Anxiety, depression, and health-related quality of life in aging people living with HIV compared to diabetes patients and patients with minor health conditions: a longitudinal study
Cited by 26
OpenAlex
Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study
Cited by 27
OpenAlex
Accuracy to 2nd International HIV-1 RNA WHO Standard: Assessment of three generations of quantitative HIV-1 RNA nucleic acid amplification tests
Cited by 26
OpenAlex
Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus‐associated Hodgkin's disease PDF
Cited by 92
OpenAlex
Research Topics
HIV Research and Treatment
(19)
HIV/AIDS drug development and treatment
(19)
HIV-related health complications and treatments
(14)
HIV/AIDS Research and Interventions
(13)
German Literature and Culture Studies
(12)
Frequent Co-Authors
Affiliations
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb (Germany)
Princeton University
Cambridge Hospital
Government of Extremadura